Home
>
US Stocks
>
Encompass Health Corporation

Encompass Health Corporation (EHC)

$62.87

-0.22

(-0.35%)▲

Market is closed - opens 7 PM, 08 Jun 2023

Insights on Encompass Health Corp

  • Increasing Revenue

    Revenue is up for the last 3 quarters, 1.08B → 1.16B (in $), with an average increase of 3.1% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 89.4M → 87.7M (in $), with an average decrease of 1.9% per quarter

  • Vs HCA

    In the last 1 year, HCA Healthcare Inc has given 30.7% return, outperforming this stock by 27.9%

  • Vs HCA

    In the last 3 years, HCA Healthcare Inc has given 134.7% return, outperforming this stock by 148.6%

Performance

  • $62.82
    $63.35
    $62.87
    downward going graph

    0.08%

    Downside

    Day's Volatility :0.84%

    Upside

    0.76%

    downward going graph
  • $41.62
    $66.44
    $62.87
    downward going graph

    33.8%

    Downside

    52 Weeks Volatility :37.36%

    Upside

    5.37%

    downward going graph

Returns

PeriodEncompass Health CorporationSector (Health Care)Index (Russel 2000)
3 Months
15.55%
2.1%
-5.8%
6 Months
10.98%
-6.4%
-2.1%
1 Year
2.8%
-1.4%
-7.8%
3 Years
-15.38%
25.7%
17.4%

Highlights

Market Capitalization
6.3B
Book Value
$13.81
Dividend Share
0.73
Dividend Yield
0.96%
Earnings Per Share (EPS)
2.82
PE Ratio
22.29
Wall Street Target Price
73.55
Profit Margin
6.09%
Operating Margin TTM
14.75%
Return On Assets TTM
6.46%
Return On Equity TTM
17.0%
Revenue TTM
4.4B
Revenue Per Share TTM
44.83
Quarterly Revenue Growth YOY
9.5%
Gross Profit TTM
1.8B
EBITDA
906.0M
Diluted Eps TTM
2.82
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
3.2
EPS Estimate Next Year
3.57
EPS Estimate Current Quarter
0.7
EPS Estimate Next Quarter
0.74

Analyst Recommendation

Buy
    87%Buy
    12%Hold
    0
    0%Sell
Based on 16 Wall street analysts offering stock ratings for Encompass Health Corporation(by analysts ranked 0 to 5 stars)
Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
14
Hold
2
2
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 16.99%

Current $62.87
Target $73.55

Company Financials

FY17Y/Y Change
Revenue
3.9B
↑ 7.49%
Net Income
256.3M
↑ 3.51%
Net Profit Margin
6.54%
↓ 0.25%
FY18Y/Y Change
Revenue
4.3B
↑ 9.14%
Net Income
292.3M
↑ 14.05%
Net Profit Margin
6.83%
↑ 0.29%
FY19Y/Y Change
Revenue
4.6B
↑ 7.66%
Net Income
358.7M
↑ 22.72%
Net Profit Margin
7.79%
↑ 0.96%
FY20Y/Y Change
Revenue
4.6B
↑ 0.86%
Net Income
284.2M
↓ 20.77%
Net Profit Margin
6.12%
↓ 1.67%
FY21Y/Y Change
Revenue
5.1B
↑ 10.27%
Net Income
412.2M
↑ 45.04%
Net Profit Margin
8.05%
↑ 1.93%
FY22Y/Y Change
Revenue
4.3B
↓ 15.09%
Net Income
271.0M
↓ 34.26%
Net Profit Margin
6.23%
↓ 1.82%
Q4 FY21Q/Q Change
Revenue
1.3B
↑ 2.64%
Net Income
91.6M
↓ 8.4%
Net Profit Margin
6.95%
↓ 0.83%
Q1 FY22Q/Q Change
Revenue
1.3B
↑ 1.13%
Net Income
87.5M
↓ 4.48%
Net Profit Margin
6.56%
↓ 0.39%
Q2 FY22Q/Q Change
Revenue
1.3B
↓ 0.23%
Net Income
48.7M
↓ 44.34%
Net Profit Margin
3.66%
↓ 2.9%
Q3 FY22Q/Q Change
Revenue
1.1B
↓ 18.11%
Net Income
45.4M
↓ 6.78%
Net Profit Margin
4.17%
↑ 0.51%
Q4 FY22Q/Q Change
Revenue
1.1B
↑ 4.39%
Net Income
89.4M
↑ 96.92%
Net Profit Margin
7.86%
↑ 3.69%
Q1 FY23Q/Q Change
Revenue
1.2B
↑ 2.03%
Net Income
87.7M
↓ 1.9%
Net Profit Margin
7.56%
↓ 0.3%
FY17Y/Y Change
Total Assets
4.9B
↑ 4.52%
Total Liabilities
3.5B
↓ 7.57%
FY18Y/Y Change
Total Assets
5.2B
↑ 5.75%
Total Liabilities
3.6B
↑ 4.29%
FY19Y/Y Change
Total Assets
6.1B
↑ 17.5%
Total Liabilities
4.4B
↑ 21.27%
FY20Y/Y Change
Total Assets
6.4B
↑ 6.01%
Total Liabilities
4.5B
↑ 2.01%
FY21Y/Y Change
Total Assets
6.9B
↑ 6.5%
Total Liabilities
4.5B
↓ 0.23%
FY22Y/Y Change
Total Assets
5.6B
↓ 17.89%
Total Liabilities
3.8B
↓ 15.48%
Q4 FY21Q/Q Change
Total Assets
6.9B
↑ 2.13%
Total Liabilities
4.5B
↑ 0.85%
Q1 FY22Q/Q Change
Total Assets
6.9B
↑ 1.15%
Total Liabilities
4.5B
↓ 0.3%
Q2 FY22Q/Q Change
Total Assets
7.1B
↑ 1.99%
Total Liabilities
4.5B
↑ 1.91%
Q3 FY22Q/Q Change
Total Assets
5.5B
↓ 22.68%
Total Liabilities
3.7B
↓ 17.84%
Q4 FY22Q/Q Change
Total Assets
5.6B
↑ 2.93%
Total Liabilities
3.8B
↑ 1.25%
Q1 FY23Q/Q Change
Total Assets
5.7B
↑ 1.97%
Total Liabilities
3.8B
↑ 0.25%
FY17Y/Y Change
Operating Cash Flow
657.2M
↑ 8.54%
Investing Cash Flow
-284.5M
↑ 16.12%
Financing Cash Flow
-358.8M
↓ 5.97%
FY18Y/Y Change
Operating Cash Flow
762.4M
↑ 16.01%
Investing Cash Flow
-424.5M
↑ 49.21%
Financing Cash Flow
-321.2M
↓ 10.48%
FY19Y/Y Change
Operating Cash Flow
635.3M
↓ 16.67%
Investing Cash Flow
-657.4M
↑ 54.86%
Financing Cash Flow
48.2M
↓ 115.01%
FY20Y/Y Change
Operating Cash Flow
704.7M
↑ 10.92%
Investing Cash Flow
-407.5M
↓ 38.01%
Financing Cash Flow
-145.9M
↓ 402.7%
FY21Y/Y Change
Operating Cash Flow
715.8M
↑ 1.58%
Investing Cash Flow
-666.3M
↑ 63.51%
Financing Cash Flow
-240.1M
↑ 64.56%
Q4 FY21Q/Q Change
Operating Cash Flow
123.8M
↓ 30.29%
Investing Cash Flow
-220.7M
↑ 77.98%
Financing Cash Flow
42.3M
↓ 328.65%
Q1 FY22Q/Q Change
Operating Cash Flow
218.9M
↑ 76.82%
Investing Cash Flow
-123.1M
↓ 44.22%
Financing Cash Flow
-60.9M
↓ 243.97%
Q2 FY22Q/Q Change
Operating Cash Flow
244.6M
↑ 11.74%
Investing Cash Flow
-123.2M
↑ 0.08%
Financing Cash Flow
-19.3M
↓ 68.31%
Q3 FY22Q/Q Change
Operating Cash Flow
70.1M
↓ 71.34%
Investing Cash Flow
-174.3M
↑ 41.48%
Financing Cash Flow
-49.0M
↑ 153.89%

Technicals Summary

Sell

Neutral

Buy

Encompass Health Corp is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Encompass Health Corporation
Encompass Health Corporation
1.38%
10.98%
2.8%
-15.38%
-3.97%
HCA Holdings, Inc.
HCA Holdings, Inc.
-2.37%
13.89%
30.68%
129.74%
157.49%
Universal Health Services Inc.
Universal Health Services Inc.
-5.01%
6.17%
11.25%
22.31%
16.72%
DaVita HealthCare Partners Inc.
DaVita HealthCare Partners Inc.
11.29%
32.67%
4.14%
14.11%
44.01%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Encompass Health Corporation
Encompass Health Corporation
22.29
22.29
NA
3.2
0.17
0.06
0.01
13.81
HCA Holdings, Inc.
HCA Holdings, Inc.
13.4
13.4
1.37
18.16
0.21
0.11
0.01
-9.04
Universal Health Services Inc.
Universal Health Services Inc.
14.33
14.33
1.87
10.18
0.11
0.05
0.01
85.67
DaVita HealthCare Partners Inc.
DaVita HealthCare Partners Inc.
17.51
17.51
0.86
6.72
0.3
0.05
0.0
9.11
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Encompass Health Corporation
Encompass Health Corporation
Buy
$6.3B
-3.97%
22.29
6.09%
HCA Holdings, Inc.
HCA Holdings, Inc.
Buy
$74.9B
157.49%
13.4
9.42%
Universal Health Services Inc.
Universal Health Services Inc.
Hold
$9.5B
16.72%
14.33
5.05%
DaVita HealthCare Partners Inc.
DaVita HealthCare Partners Inc.
Hold
$9.0B
44.01%
17.51
4.41%

Institutional Holdings

  • BlackRock Inc

    11.21%

  • Vanguard Group Inc

    9.87%

  • Wellington Management Company LLP

    9.54%

  • William Blair Investment Management, LLC

    5.30%

  • JPMorgan Chase & Co

    3.00%

  • State Street Corporation

    2.87%

Corporate Announcements

  • Encompass Health Corporation Dividends March,2023

    In the quarter ending March,2023. Encompass Health Corporation has declared dividend of $0.15

    Read More

Company Information

as a national leader of post-acute care, encompass health offers facility-based and home-based patient care through our network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. we are committed to delivering high-quality, cost-effective care across the post-acute continuum. driven by a set of shared values, encompass health is the result of the union between healthsouth corporation and encompass home health & hospice.our approach to post-acute care sets us apart. we firmly believe that every success starts with our dedicated team of professionals, so we make sure they are empowered with the tools they need to help our patients be successful. innovative technologies, advanced therapies, customized treatment plans, coordinated care teams – these are all part of our promise to deliver the highest level of care.

Organization
Encompass Health Corporation
Employees
35900
CEO
Mr. Mark J. Tarr
Industry
Health Services

Discover More

FAQs